Ireland increases "free sale" certificate fees:
This article was originally published in Clinica
Executive Summary
The Irish Medicines Board (IMB) has increased its fees for certificates of free sale as of September 1 2006.These are sometimes needed by medtech companies for export, with countries in Asia and South America requiring them for registration purposes. To obtain certificates issued within two working days, it now costs Euro130 ($164), and Euro246 to have them issued within one day. Additional copies of certificates, available at the time of the initial request, remain at Euro20 a copy.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.